Healthcare

In 2014, the Australian aged care market was worth A$14 billion and is expected to grow at an annual rate of four per cent for the next five years (2015-2020). Of the total market, A$9.5 billion was provided by the federal government, while the remainder of A$4.5 billion was privately funded by companies and residents. Australian aged care systems ...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiolo...

The 2015 HIMSS Annual Conference and Exhibition, a key event for the health IT industry, held on April 12-16, 2015 in Chicago provided a comprehensive overview of the state of the market from the perspective of various stakeholders, including health IT vendors, healthcare providers, and government regulators, and as a reliable harbinger for what is...

This issue analyses artificial organs.

This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from p...

This study assesses marketed and in-research products and combination regimens for the lung cancer therapeutics market. Segmentation by drug class is provided, along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are...

In this first Customer Experience Management report for Malaysias Medical Insurance industry, Frost & Sullivan explores the relationship of the experiences provided by medical insurance companies for its customers. We look at the critical factors that influence customer behaviours throughout the three phases (pre-purchase, purchase and post-purcha...

In this first Customer Experience Management report for Singapore's Medical Insurance industry, Frost & Sullivan explores the relationship of the experiences provided by medical insurance companies for its customers. We look at the critical factors that influence customer behaviours throughout the three phases (pre-purchase, purchase and post-purch...